Comparison of ketamine stereoisomers on tissue metabolic activity in an in vitro model of global cerebral ischaemia (Q32062146)

6 July 2017

title

Comparison of ketamine stereoisomers on tissue metabolic activity in an in vitro model of global cerebral ischaemia (English)

1 reference

6 July 2017

1 reference

Mathews KS

1

1 reference

6 July 2017

Toner CC

series ordinal

2

1 reference

6 July 2017

McLaughlin DP

series ordinal

3

1 reference

6 July 2017

Stamford JA

series ordinal

4

1 reference

6 July 2017

publication date

1 April 2001

1 reference

Neurochemistry International

6 July 2017

published in

1 reference

6 July 2017

volume

38

1 reference

6 July 2017

issue

5

1 reference

6 July 2017

page(s)

367-372

1 reference

Dopamine depletion protects striatal neurons from ischemia-induced cell death

6 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900125-X

7 January 2021

Synergistic inhibition of muscarinic signaling by ketamine stereoisomers and the preservative benzethonium chloride

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900125-X

7 January 2021

[Recovery time after (S)-ketamine or ketamine racemate. Recovery time after short anesthesia in volunteers]

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900125-X

7 January 2021

Stereospecific effects of ketamine on dopamine efflux and uptake in the rat nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900125-X

7 January 2021

The clinical use of S-(+)-ketamine--a determination of its place

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900125-X

7 January 2021

The development of tolerance to ketamine in rats and the significance of hepatic metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900125-X

7 January 2021

Ketamine prevents ischemic neuronal injury

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900125-X

7 January 2021

Ketamine acts as a non-competitive N-methyl-D-aspartate antagonist on frog spinal cord in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900125-X

7 January 2021

Rapid quantification of ischaemic injury and cerebroprotection in brain slices using densitometric assessment of 2,3,5-triphenyltetrazolium chloride staining.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900125-X

7 January 2021

Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900125-X

7 January 2021

Neuronal mechanisms of ketamine-induced anesthesia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900125-X

7 January 2021

Ketamine stereoselectively inhibits rat dopamine transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900125-X

7 January 2021

Ketamine, MK-801 or calmidazolium protects rat hippocampal energy status during in vitro ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900125-X

7 January 2021

Comparative pharmacology of the optical isomers of ketamine in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900125-X

7 January 2021

Ascorbic acid is neuroprotective against global ischaemia in striatum but not hippocampus: histological and voltammetric data

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900125-X

7 January 2021

Characteristics of the NMDA receptor modulating hypoxia/hypoglycaemia-induced rat striatal dopamine release in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900125-X

7 January 2021

Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900125-X

7 January 2021

[Ketamine racemate and S-(+)-ketamine. Cerebrovascular effects and neuroprotection following focal ischemia]

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900125-X

7 January 2021

Ketamine--its pharmacology and therapeutic uses.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-0186%2800%2900125-X

7 January 2021

10.1016/S0197-0186(00)00125-X

Identifiers

DOI

1 reference

6 July 2017

1 reference